Dementia treatment

FDA approves lecanemab, first new Alzheimer’s drug in nearly 20 years

The U.S. Food and Drug Administration has granted full approval to lecanemab, a treatment for early Alzheimer’s disease, marking the first new drug of its kind in nearly two decades. The decision…